IBM's AI blood test could help with early Alzheimer's detection

Engadget 

Previous attempts to find a cure for Alzheimer's ended up in failure, but a new study out of IBM Research has the potential to spark a major breakthrough. A group of IBM researchers have harnessed the powers of machine learning to figure out a way to detect a biological marker associated with the disease -- a peptide called amyloid-beta -- with a simple blood test. The solution they came up with can even detect an individual's risk for Alzheimer's earlier than a brain scan can and way before symptoms start showing up. It can arm doctors with the ammo they need to be able to take better care of their patients. According to a study published in 2017, the concentration of amyloid-beta in a person's spinal fluid starts changing decades before the first signs of the disease show up.